December 1, 2021 Life Science Tools M&A, Partnerships Product Launch

Roche completes purchase agreement with long-term partner TIB Molbiol to expand PCR-test portfolio in the fight against new infectious diseases

TIB Molbiol excels in ultra-rapid assay development for emerging infectious disease, strongly demonstrated during the COVID-19 pandemic The acquisition enables Roche to further expand the portfolio of currently over 45 CE-IVD assays and more than 100 research use assays on Roche’s LightCycler PCR instruments TIB Molbiol will continue to focus on the research and development... Read more

November 30, 2021 Lab Top-10 Product Launch

New High Fidelity CRISPR Cas9 Protein Reduces Off-target Effects for More Precise Genome Editing

New High Fidelity CRISPR Cas9 Protein Reduces Off-target Effects for More Precise Genome Editing Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications CARLSBAD, Calif., Nov. 30, 2021 /PRNewswire/ — For research applications requiring highly precise genome editing, including engineering CAR T cells and creating cellular models for disease discovery, the Invitrogen... Read more

November 30, 2021 Product Launch

GE Healthcare Announces Three New Alliances to Help Improve Cancer Care

Collaborations with SOPHiA GENETICS, The University of Cambridge and Optellum are intended expand access to the latest and most advanced technologies for cancer care Chicago, Nov 30 2021 — GE Healthcare announced collaborations with SOPHiA GENETICS, The University of Cambridge and Optellum as part of its vision to advance care, make precision health more accessible,... Read more

November 28, 2021 Product Launch

GE Healthcare Unveils New AI and Digital Technologies and Solutions to Help Solve Healthcare’s Most Pressing Problems

Chicago — November 28, 2021 – At the Radiological Society of North America’s (RSNA) 2021 Annual Meeting, GE Healthcare unveiled around 60 innovative technology solutions spanning the healthcare spectrum including patient screening, diagnostics, therapy planning, guidance, and monitoring. Amidst a global pandemic and mounting pressure on the industry, the company accelerated innovations underpinned by artificial... Read more

November 23, 2021 PAI Top-10 Product Launch

Roche to present new pivotal data at ASH 2021 from broad and comprehensive portfolio, challenging treatment standards for people with blood disorders

Phase III POLARIX trial showed Polivy plus R-CHP was the first treatment in two decades to significantly improve outcomes in newly diagnosed diffuse large B-cell lymphoma (DLBCL) versus the standard of care1 Pivotal data on mosunetuzumab, a potential first-in-class CD20xCD3 T-cell engaging bispecific antibody, showed high response rates in relapsed or refractory follicular lymphoma (FL)2... Read more

November 22, 2021 Chromatography Product Launch

Daicel Chiral Technologies Announces the Launch of CHIRALPAK® IK

November 22, 2021 For Immediate Release Daicel Chiral Technologies Announces the Launch of CHIRALPAK® IK West Chester, PA (November 22, 2021) —Daicel Chiral Technologies today announced the introduction of CHIRALPAK® IK, adding new selectivity capabilities to the Daicel portfolio. This new immobilized selector builds on the success of CHIRALPAK IG, one of the most effective chiral chromatography phases... Read more

November 22, 2021 Informatics & Software Lab Top-10 Liq. Handling & Robotics Product Launch

PerkinElmer Launches Cloud Based Solution to Enable Remote Lab Management

The PKeye Workflow Monitor offers 24/7 monitoring capabilities to ensure high productivity and throughput WALTHAM, Mass. – November 22, 2021 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its PKeye™ Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer... Read more

November 19, 2021 PR/Corporate Product Launch

PacBio Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., Nov. 19, 2021 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 80,000 shares of PacBio common stock, and restricted stock units (“RSUs”) covering 40,000 shares... Read more

November 18, 2021 Licensing, IP, and Legal Product Launch

Xylem Announces New Investor Relations Leadership

RYE BROOK, N.Y.–(BUSINESS WIRE)–Nov. 18, 2021– Xylem Inc. (NYSE: XYL), a leading global water technology company, today announced a change in the leadership of its Investor Relations team. Matthew Latino, currently Vice President, Investor Relations, is appointed Vice President, Finance, of Xylem’s Applied Water Systems (AWS) business and the Americas Commercial Team (ACT), effective January... Read more